DNTH in the 13F filings
Dianthus Therapeutics Inc · CUSIP 252828108
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 27
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 6 listed it in both
- Shares listed
- 18,587,279
- combined, among listed positions
- Reported value
- $1.5bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 17 buyers (opened or added shares) and 14 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +2,614,817.
Managers listing DNTH in Q1 2026
27 of 27 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 7,767,686 shares now+1,336,357
- Farallon Capital Management LLCnew position · 836,000 shares now+836,000
- Citadel Advisors LLCexisting position · 1,610,483 shares now+541,549
- T. Rowe Price Associates Incexisting position · 1,146,948 shares now+530,915
- Balyasny Asset Management LLCnew position · 474,085 shares now+474,085
Reductions
- Marshall Wace LLPexisting position · 341,929 shares now-666,604
- Point72 Asset Management LPexisting position · 643,599 shares now-522,489
- Millennium Management LLCexisting position · 261,962 shares now-405,254
- Squarepoint Ops LLCexisting position · 38,738 shares now-168,381
- ExodusPoint Capital Management LPexisting position · 85,530 shares now-161,258
New positions and exits
New (8)
Exited (4)
- Two Sigma Investments LPwas $2.0m
- Jane Street Group LLCwas $1.9m
- Voloridge Investment Management LLCwas $1.6m
- Renaissance Technologies LLCwas $1.3m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2024 | 1 | $2.4m | 1 | 0 |
| Q2 2024 | 1 | $6.5m | 1 | 0 |
| Q3 2024 | 1 | $6.9m | 1 | 0 |
| Q4 2024 | 1 | $6.6m | 1 | 0 |
| Q1 2025 | 2 | $32m | 1 | 0 |
| Q2 2025 | 2 | $33m | 1 | 1 |
| Q3 2025 | 1 | $80m | 1 | 0 |
| Q4 2025 | 6 | $118m | 21 | 4 |
| Q1 2026 | 13 | $1.2bn | 17 | 14 |
| Q2 2026 | 6 | $1.4bn | 9 | 21 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
DNTH and LLY →DNTH and JNJ →DNTH and VRTX →Choose a stock to compare with DNTH →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own DNTH, latest filings →Back to the 13F Explorer →